相关实验视频
Updated: Feb 7, 2026

10:56
Co-localization of Cell Lineage Markers and the Tomato Signal
Published on: December 28, 2016
12.7K
P2RX5的祖先单体型产生了一个B细胞表面标记物和一个多谱系免疫疗法点
bioRxiv : the preprint server for biology
|February 6, 2026
概括
一个新的目标,P2RX5,被确定用于癌症免疫疗法. 这种蛋白质在B细胞瘤,T细胞急性淋巴细胞白血病和多发性髓瘤中表达,为治疗提供了新的途径.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 目前针对CD19和BCMA的免疫疗法在B细胞和血细胞癌症中取得了成功,但由于抗原损失和复发而面临挑战.
- 迫切需要新的治疗点来克服血液恶性瘤中的抗原逃生机制.
研究的目的:
- 在B细胞和血细胞恶性瘤中识别和描述免疫治疗的新目标.
- 评估向P2RX5在血液癌症中的治疗潜力,包括T细胞急性淋巴细胞白血病 (T-ALL) 和多发性髓瘤 (MM).
主要方法:
- 转录组数据集和新型单克隆抗体被用于识别和验证P2RX5表达.
- 开发和测试了P2RX5导向的两种特异性T细胞参与者和仿真抗原受体 (CAR) T细胞.
- 实验室和体内模型,包括细胞培养和Burkitt淋巴瘤和MM的异种移植,用于有效性评估.
主要成果:
- P2RX5在80%的非洲血统个体中编码了一个稳定的蛋白质,并表现出B细胞谱系受限的表达.
- P2RX5在B细胞瘤,T-ALL和MM中表达,使其成为多谱系标.
- 针对P2RX5的免疫疗法表现出与现有治疗方法相当的疗效,并保持了对CD19/BCMA阴性变异的有效性.
结论:
- P2RX5代表了多种血液性恶性瘤免疫治疗的有希望的新型标.
- 基于P2RX5的疗法为克服抗原损失和治疗复发性或耐火性癌症提供了潜在的策略.
相关概念视频
ATP Yield
79.0K
Cellular respiration produces 30 - 32 ATP per glucose molecule. Although most of the ATP results from oxidative phosphorylation and the electron transport chain (ETC), 4 ATP are gained beforehand (2 from glycolysis and 2 from the citric acid cycle).
The ETC is embedded in the inner mitochondrial membrane and is comprised of four main protein complexes and an ATP synthase. NADH and FADH2 pass electrons to these complexes, which pump protons into the intermembrane space. This distribution of...
The ETC is embedded in the inner mitochondrial membrane and is comprised of four main protein complexes and an ATP synthase. NADH and FADH2 pass electrons to these complexes, which pump protons into the intermembrane space. This distribution of...
79.0K
Reaction Yield
60.0K
The theoretical yield of a reaction is the amount of product estimated to form based on the stoichiometry of the balanced chemical equation. The theoretical yield assumes the complete conversion of the limiting reactant into the desired product. The amount of product that is obtained by performing the reaction is called the actual yield, and it may be less than or (very rarely) equal to the theoretical yield.
60.0K
Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Cell-surface Signaling
54.5K
Hormones—or any molecule that binds to a receptor, known as a ligand—that are lipid-insoluble (water-soluble) are not able to diffuse across the cell membrane. In order to be able to affect a cell without entering it, these hormones bind to receptors on the cell membrane. When a first messenger, a hormone, binds to a receptor, a signal cascade is set off, causing second messengers, proteins inside the cell, to become activated, resulting in downstream effects.
54.5K
Lineage Commitment
4.4K
Commitment is the process whereby stem cells:
4.4K
Target Cell Response to Hormones
5.8K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.8K

